BiotechTube
Bio-Xtal

Bio-Xtal

Strasbourg, France· Est.
bioxtal.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

BioXtal is a long-established, private French CRO that has evolved from providing general R&D services to developing a proprietary technology platform. Its core business remains fee-for-service work in protein sciences and structural biology. The company's strategic shift is marked by the 2024 creation of a spin-off to focus on commercializing its SNPXplex® reagent, a product for NGS sample identity tracking, signaling a move into the diagnostics and personalized medicine tools market. This positions BioXtal as a hybrid service-provider and product-developer.

Drug DeliveryProteomics

Technology Platform

Platform for protein production, structural biology, and nanobody generation (service). Proprietary SNPXplex® reagent for NGS sample identity tracking and verification (product).

Opportunities

The global expansion of clinical NGS and personalized medicine creates a growing need for robust sample tracking solutions like SNPXplex®.
The prestigious partnership with AP-HP provides a powerful validation and entry point into the French and European clinical genomics market.
The spin-off structure allows focused R&D to rapidly iterate and improve the product platform.

Risk Factors

Market adoption of SNPXplex® faces competition from existing sample management methods and potential new entrants.
The success of the HMGx Sample Tracking spin-off is unproven and introduces execution risk, including the need for dedicated commercial and manufacturing capabilities.
The core CRO business may face client concentration or pricing pressures.

Competitive Landscape

In CRO services, BioXtal competes with other specialized protein production and structural biology labs globally. For SNPXplex®, competition includes laboratory-developed sample tracking methods, sample management software, and potential integrated solutions from large NGS platform providers (e.g., Illumina, Thermo Fisher). Its differentiation lies in being a dedicated, chemistry-based reagent for genetic sample ID.

More companies in Small Molecule Drugs →More companies in France →